Cargando…
mTORC1-c-Myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A
BACKGROUND: Exploiting cancer metabolism during nutrient availability holds immense potential for the clinical and therapeutic benefits of hepatocellular carcinoma (HCC) patients. Dietary methionine is a metabolic dependence of cancer development, but how the signal transduction integrates methionin...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652997/ https://www.ncbi.nlm.nih.gov/pubmed/36371321 http://dx.doi.org/10.1186/s13578-022-00919-y |
_version_ | 1784828595645972480 |
---|---|
author | Zhao, Liang Su, Huizhao Liu, Xiaomeng Wang, Hongquan Feng, Yukuan Wang, Yan Chen, Haiqiang Dai, Luo Lai, Shihui Xu, Siqi Li, Chong Hao, Jihui Tang, Bo |
author_facet | Zhao, Liang Su, Huizhao Liu, Xiaomeng Wang, Hongquan Feng, Yukuan Wang, Yan Chen, Haiqiang Dai, Luo Lai, Shihui Xu, Siqi Li, Chong Hao, Jihui Tang, Bo |
author_sort | Zhao, Liang |
collection | PubMed |
description | BACKGROUND: Exploiting cancer metabolism during nutrient availability holds immense potential for the clinical and therapeutic benefits of hepatocellular carcinoma (HCC) patients. Dietary methionine is a metabolic dependence of cancer development, but how the signal transduction integrates methionine status to achieve the physiological demand of cancer cells remains unknown. METHODS: Low or high levels of dietary methionine was fed to mouse models with patient-derived xenograft or diethyl-nitrosamine induced liver cancer. RNA sequence and metabolomics were performed to reveal the profound effect of methionine restriction on gene expression and metabolite changes. Immunostaining, sphere formation assays, in vivo tumourigenicity, migration and self-renewal ability were conducted to demonstrate the efficacy of methionine restriction and sorafenib. RESULTS: We discovered that mTORC1-c-Myc-SIRT4 axis was abnormally regulated in a methionine-dependent manner and affected the HCC progression. c-Myc rewires methionine metabolism through TRIM32 mediated degradation of SIRT4, which regulates MAT2A activity by ADP-ribosylation on amino acid residue glutamic acid 111. MAT2A is a key enzyme to generate S-adenosylmethionine (SAM). Loss of SIRT4 activates MAT2A, thereby increasing SAM level and dynamically regulating gene expression, which triggers the high proliferation rate of tumour cells. SIRT4 exerts its tumour suppressive function with targeted therapy (sorafenib) by affecting methionine, redox and nucleotide metabolism. CONCLUSIONS: These findings establish a novel characterization of the signaling transduction and the metabolic consequences of dietary methionine restriction in malignant liver tissue of mice. mTORC1, c-Myc, SIRT4 and ADP ribosylation site of MAT2A are promising clinical and therapeutic targets for the HCC treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13578-022-00919-y. |
format | Online Article Text |
id | pubmed-9652997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96529972022-11-15 mTORC1-c-Myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A Zhao, Liang Su, Huizhao Liu, Xiaomeng Wang, Hongquan Feng, Yukuan Wang, Yan Chen, Haiqiang Dai, Luo Lai, Shihui Xu, Siqi Li, Chong Hao, Jihui Tang, Bo Cell Biosci Research BACKGROUND: Exploiting cancer metabolism during nutrient availability holds immense potential for the clinical and therapeutic benefits of hepatocellular carcinoma (HCC) patients. Dietary methionine is a metabolic dependence of cancer development, but how the signal transduction integrates methionine status to achieve the physiological demand of cancer cells remains unknown. METHODS: Low or high levels of dietary methionine was fed to mouse models with patient-derived xenograft or diethyl-nitrosamine induced liver cancer. RNA sequence and metabolomics were performed to reveal the profound effect of methionine restriction on gene expression and metabolite changes. Immunostaining, sphere formation assays, in vivo tumourigenicity, migration and self-renewal ability were conducted to demonstrate the efficacy of methionine restriction and sorafenib. RESULTS: We discovered that mTORC1-c-Myc-SIRT4 axis was abnormally regulated in a methionine-dependent manner and affected the HCC progression. c-Myc rewires methionine metabolism through TRIM32 mediated degradation of SIRT4, which regulates MAT2A activity by ADP-ribosylation on amino acid residue glutamic acid 111. MAT2A is a key enzyme to generate S-adenosylmethionine (SAM). Loss of SIRT4 activates MAT2A, thereby increasing SAM level and dynamically regulating gene expression, which triggers the high proliferation rate of tumour cells. SIRT4 exerts its tumour suppressive function with targeted therapy (sorafenib) by affecting methionine, redox and nucleotide metabolism. CONCLUSIONS: These findings establish a novel characterization of the signaling transduction and the metabolic consequences of dietary methionine restriction in malignant liver tissue of mice. mTORC1, c-Myc, SIRT4 and ADP ribosylation site of MAT2A are promising clinical and therapeutic targets for the HCC treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13578-022-00919-y. BioMed Central 2022-11-12 /pmc/articles/PMC9652997/ /pubmed/36371321 http://dx.doi.org/10.1186/s13578-022-00919-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhao, Liang Su, Huizhao Liu, Xiaomeng Wang, Hongquan Feng, Yukuan Wang, Yan Chen, Haiqiang Dai, Luo Lai, Shihui Xu, Siqi Li, Chong Hao, Jihui Tang, Bo mTORC1-c-Myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A |
title | mTORC1-c-Myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A |
title_full | mTORC1-c-Myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A |
title_fullStr | mTORC1-c-Myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A |
title_full_unstemmed | mTORC1-c-Myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A |
title_short | mTORC1-c-Myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A |
title_sort | mtorc1-c-myc pathway rewires methionine metabolism for hcc progression through suppressing sirt4 mediated adp ribosylation of mat2a |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652997/ https://www.ncbi.nlm.nih.gov/pubmed/36371321 http://dx.doi.org/10.1186/s13578-022-00919-y |
work_keys_str_mv | AT zhaoliang mtorc1cmycpathwayrewiresmethioninemetabolismforhccprogressionthroughsuppressingsirt4mediatedadpribosylationofmat2a AT suhuizhao mtorc1cmycpathwayrewiresmethioninemetabolismforhccprogressionthroughsuppressingsirt4mediatedadpribosylationofmat2a AT liuxiaomeng mtorc1cmycpathwayrewiresmethioninemetabolismforhccprogressionthroughsuppressingsirt4mediatedadpribosylationofmat2a AT wanghongquan mtorc1cmycpathwayrewiresmethioninemetabolismforhccprogressionthroughsuppressingsirt4mediatedadpribosylationofmat2a AT fengyukuan mtorc1cmycpathwayrewiresmethioninemetabolismforhccprogressionthroughsuppressingsirt4mediatedadpribosylationofmat2a AT wangyan mtorc1cmycpathwayrewiresmethioninemetabolismforhccprogressionthroughsuppressingsirt4mediatedadpribosylationofmat2a AT chenhaiqiang mtorc1cmycpathwayrewiresmethioninemetabolismforhccprogressionthroughsuppressingsirt4mediatedadpribosylationofmat2a AT dailuo mtorc1cmycpathwayrewiresmethioninemetabolismforhccprogressionthroughsuppressingsirt4mediatedadpribosylationofmat2a AT laishihui mtorc1cmycpathwayrewiresmethioninemetabolismforhccprogressionthroughsuppressingsirt4mediatedadpribosylationofmat2a AT xusiqi mtorc1cmycpathwayrewiresmethioninemetabolismforhccprogressionthroughsuppressingsirt4mediatedadpribosylationofmat2a AT lichong mtorc1cmycpathwayrewiresmethioninemetabolismforhccprogressionthroughsuppressingsirt4mediatedadpribosylationofmat2a AT haojihui mtorc1cmycpathwayrewiresmethioninemetabolismforhccprogressionthroughsuppressingsirt4mediatedadpribosylationofmat2a AT tangbo mtorc1cmycpathwayrewiresmethioninemetabolismforhccprogressionthroughsuppressingsirt4mediatedadpribosylationofmat2a |